FORCED TITRATION STUDY OF TEVETEN ENALAPRIL IN AFRICAN AMERICANS W/ H

非洲裔美国人中 TEVETEN 依那普利的强制滴定研究

• 批准号: 6303812
• 负责人: ROBERT HARRISON
• 金额: $ 1.48万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-12-01 至 2001-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6303812
• 关键词: African American; cardiovascular disorder chemotherapy; clinical research; combination chemotherapy; drug /agent; drug adverse effect; drug screening /evaluation; enalapril; essential hypertension; human subject; human therapy evaluation; oral administration; placebos

The purpose of this study is to compare the safety and effectiveness of Teveten taken orally once daily, to that of a placebo and an approved and marketed antihypertensive drug, enalapril, over a 12 week period. This protocol will study African-American patients with essential hypertension during usual salt intake and with salt supplementation.

本研究的目的是比较Teveten口服每日一次的安全性和有效性，安慰剂和批准和上市的抗高血压药物依那普利，超过12周。 本方案将研究非裔美国原发性高血压患者在常规盐摄入和盐补充期间的情况。